Replit Agent vs Windsurf
Detailed side-by-side comparison to help you choose the right tool
Replit Agent
🟢No CodeAI Development Assistants
AI coding agent that builds applications from scratch in a collaborative cloud environment. Creates, deploys, and iterates on projects.
Was this helpful?
Starting Price
ContactWindsurf
🟡Low Codedeveloper-tools
The first agentic IDE with AI-powered coding assistance and MCP support
Was this helpful?
Starting Price
FreeFeature Comparison
Scroll horizontally to compare details.
Replit Agent - Pros & Cons
Pros
- ✓Complete end-to-end development from natural language requirements to deployed, accessible applications in a single workflow
- ✓Cloud-based development environment eliminates local setup requirements and provides instant accessibility from any device
- ✓Automatic technology stack selection and configuration based on project requirements and best practices
- ✓Collaborative iteration through natural language conversation with real-time code modification and explanation
- ✓Instant deployment and sharing capabilities with automatic hosting and URL generation for immediate application access
Cons
- ✗Limited to Replit's cloud environment, preventing use of specialized development tools or local development preferences
- ✗Subscription costs can accumulate for multiple projects or extended development time
- ✗Code portability concerns if you need to move projects to other platforms or hosting environments
Windsurf - Pros & Cons
Pros
- ✓Comprehensive feature set
- ✓Regular updates and improvements
- ✓Professional support available
Cons
- ✗Initial setup and configuration time required
- ✗Subscription cost adds up for multiple users
Not sure which to pick?
🎯 Take our quiz →🔒 Security & Compliance Comparison
Scroll horizontally to compare details.
🦞
🔔
Price Drop Alerts
Get notified when AI tools lower their prices
Get weekly AI agent tool insights
Comparisons, new tool launches, and expert recommendations delivered to your inbox.
Ready to Choose?
Read the full reviews to make an informed decision